Lars Klareskog
Rheumatology Unit
Department of Medicine
Karolinska Institutet and Karolinska University Hospital
Stockholm
Sweden
Name/email consistency: high
- Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis. Klareskog, L., Gaubitz, M., Rodríguez-Valverde, V., Malaise, M., Dougados, M., Wajdula, J. Clin. Exp. Rheumatol. (2011)
- On the origins of complex immune-mediated disease: the example of rheumatoid arthritis. Klareskog, L., Wedrén, S., Alfredsson, L. J. Mol. Med. (2009)
- Immunity to citrullinated proteins in rheumatoid arthritis. Klareskog, L., Rönnelid, J., Lundberg, K., Padyukov, L., Alfredsson, L. Annu. Rev. Immunol. (2008)
- Antibodies to citrullinated proteins in arthritis: pathology and promise. Klareskog, L., Widhe, M., Hermansson, M., Rönnelid, J. Curr. Opin. Rheumatol (2008)
- Smoking as a trigger for inflammatory rheumatic diseases. Klareskog, L., Padyukov, L., Alfredsson, L. Curr. Opin. Rheumatol (2007)
- Genes, environment and immunity in the development of rheumatoid arthritis. Klareskog, L., Padyukov, L., Rönnelid, J., Alfredsson, L. Curr. Opin. Immunol. (2006)